The title compound is obtained from the reaction of (Me3Si)3SiLi(thf)3 with CuBr in n-hexane and structurally characterised by X-ray diffraction; in [Cu2R2BrLi(thf)3], R = Si(SiMe3)3 one silyl ligand is bridging a very short Cu–Cu bond, resulting in a three-centre two-electron bond, while the second is terminally bound to copper; the other copper atom is linked to a lithium atom via a Cu ⋯ Br ⋯ Li bridge.
No takes yet. Share an insight, caveat, or question.
Heine et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: